Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Richter Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Amiens-Picardie Chu, Amiens, France
Contact: Study coordinator (Caroline DELETTE, MD) · delette.caroline@chu-amiens.fr · +33322455914
Angers Chu, Angers, France
Contact: Study coordinator (Aline CLAVERT, MD) · aline.clavert@chu-angers.fr · +33 2 41 35 45 24
BAYONNE - CH de la Côte Basque - Hématologie, Bayonne, France
Contact: Study coordinator (Sophie BERNARD, Dr) · sbernard@ch-cotebasque.fr
Clermont-Ferrand - Chu Estaing, Clermont-Ferrand, France
Contact: Study coordinator (Romain Guieze, MD) · rguieze@chu-clermontferrand.fr · +33473750766
Grenoble - CHUGA - Hématologie Clinique, Grenoble, France
Contact: Study coordinator (Luciel BUSSOT, Dr) · lbussot@chu-grenoble.fr
LILLE GHICL - Hôpital Saint Vincent de Paul, Lille, France
Contact: Study coordinator (Bénédicte HIVERT, Dr) · hivert.benedicte@ghicl.net · 33 (0)3 20 87 45 32
LILLE CHU - Hôpital Claude Huriez, Lille, France
Contact: Study coordinator (Morgane NUDEL) · morgane.nudel@chru-lille.fr
LIMOGES - CHU Dupuytren 1, Limoges, France
Contact: Study coordinator (Nataliya DMYTRUC) · nataliya.dmytruk@chu-limoges.fr
LYON-Centre Léon Bérard, Lyon, France
Contact: Study coordinator (Anne-Sophie MICHALLET, MD) · anne-sophie.michallet@lyon.unicancer.fr
MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique, Montpellier, France
Contact: Study coordinator (Charles HERBAUX, Dr) · c-herbaux@chu-montpellier.fr
APHP - Hôpital Saint-Louis - Hématologie adultes, Paris, France
Contact: Study coordinator (Alexandra JUDET, Dr) · alexandra.judet@aphp.fr
APHP - Hôpital Saint-Antoine - Hématologie et thérapie cellulaire, Paris, France
Contact: Study coordinator (Nicolas STOCKER, Dr) · nicolas.stocker@aphp.fr
APHP - Hôpital Pitié Salpêtrière - Hématologie, Paris, France
Contact: Study coordinator (Damien ROOS-WEIL, Pr) · damien.roos-weil@psl.aphp.fr · 01 42 16 28 24
Bordeaux Pessac, Pessac, France
Contact: Study coordinator (Marie-Sarah DILHUYDY, MD) · marie-sarah.dilhuydy@chu-bordeaux.fr · +33557656511
LYON HCL - CH Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Emmanuelle FERRAND, MD) · emmanuelle.ferrant2@chu-lyon.fr
Reims Chu, Reims, France
Contact: Study coordinator (Anne QUINQUENEL, Pr) · aquinquenel@chu-reims.fr · 33 (0)3 26 78 36 44
RENNES - CHU Pontchaillou - Hématologie Clinique, Rennes, France
Contact: Study coordinator (Sophie DE GUIBERT, Pr) · sophie.de.guibert@chu-rennes.fr · 02 99 28 42 91
ROUEN - Centre Henri Becquerel - Service Hématologie Clinique, Rouen, France
Contact: Study coordinator (Stéphane LEPRETRE, Pr) · stephane.lepretre@chb.unicancer.fr · +33 2 32 08 29 46
Strasbourg - Icans, Strasbourg, France
Contact: Study coordinator (Luc FORNECKER, MD) · lm.fornecker@icans.eu
Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse, France
Contact: Study coordinator (Loïc YSEBAERT, Pr) · ysebaert.loic@iuct-oncopole.fr
TOURS - Hôpital Bretonneau, Tours, France
Contact: Study coordinator (Caroline DARTIGEAS, MD) · c.dartigeas@chu-tours.fr
NANCY - CHU Brabois, Vandœuvre-lès-Nancy, France
Contact: Study coordinator (Pierre FEUGIER, Pr) · p.feugier@chru-nancy.fr · 33 (0)3 83 15 32 82
VERSAILLES - Hôpital André Mignot, Versailles, France
Contact: Study coordinator (Fatiha MERABET, Dr)

Study leads

Romain guièze, MD
Principal Investigator
Service d'hématologie clinique adulte et de thérapie cellulaire Etablissement : CHU Estaing

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

B-cell Lymphoma · Burkitt Lymphoma · Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Valhalla, United States

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia · Richter Syndrome · Small Lymphocytic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States · Rochester, United States

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

Richter Syndrome · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

New York, United States · New York, United States